These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2679219)

  • 1. The current status of allergen immunotherapy (hyposensitisation). Report of a WHO/IUIS working group.
    Allergy; 1989 Aug; 44(6):369-79. PubMed ID: 2679219
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of allergen immunotherapy (hyposensitization). Report of a WHO/IUIS working Group.
    Allerg Immunol (Leipz); 1989; 35(4):235-47. PubMed ID: 2696375
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.
    Bull World Health Organ; 1989; 67(3):263-72. PubMed ID: 2670296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].
    Malling HJ
    Ugeskr Laeger; 1989 Nov; 151(48):3249-52. PubMed ID: 2595857
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of allergen immunotherapy. Shortened version of a World Health Organisation/International Union of Immunological Societies Working Group Report.
    Lancet; 1989 Feb; 1(8632):259-61. PubMed ID: 2563421
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergen immunotherapy.
    Ewan PW
    Curr Opin Immunol; 1989 Apr; 1(4):672-8. PubMed ID: 2679719
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for systemic reactions to allergen-specific subcutaneous immunotherapy.
    Iglesias-Cadarso A; Hernández-Weigand P; Reaño M; Pérez-Pimiento A; Vargas Núñez JA; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(7):621-2. PubMed ID: 21314007
    [No Abstract]   [Full Text] [Related]  

  • 8. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-specific immunotherapy: current concepts and future directions.
    Bieber T; Simon HU
    Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific immunotherapy in allergies--evaluation of current status].
    Jarisch R; Hemmer W
    Wien Med Wochenschr; 1996; 146(15):422-5. PubMed ID: 9012204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New routes and formulations for allergen-specific immunotherapy.
    Wheeler AW; Drachenberg KJ
    Allergy; 1997 Jun; 52(6):602-12. PubMed ID: 9226053
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy with allergens.
    Creticos PS; Norman PS
    JAMA; 1987 Nov; 258(20):2874-80. PubMed ID: 3312669
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergen immunotherapy.
    Mannan S
    Immunotherapy; 2017 Nov; 9(15):1199-1200. PubMed ID: 29130796
    [No Abstract]   [Full Text] [Related]  

  • 14. Future Horizons in Allergy.
    Marino MJ; Luong AU
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1185-1193. PubMed ID: 28992950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological mechanisms of allergen-specific immunotherapy.
    Larché M; Akdis CA; Valenta R
    Nat Rev Immunol; 2006 Oct; 6(10):761-71. PubMed ID: 16998509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of immunotherapy in treatment of IgE-induced allergic diseases].
    Müller UR
    Ther Umsch; 1994 Jan; 51(1):67-76. PubMed ID: 7511841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the factor that improves adherence to allergen-specific immunotherapy? A secretary!
    Lombardi C
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):530-1. PubMed ID: 25863450
    [No Abstract]   [Full Text] [Related]  

  • 19. [Allergen-specific immunotherapy--vaccination against allergy].
    Brygge T; Mosbech H
    Ugeskr Laeger; 2000 Jan; 162(4):524-7. PubMed ID: 10697458
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal dosing of allergen immunotherapy: efficacy, safety, long-lasting effect.
    Senna G; Crivellaro MA; Bonadonna P; Dama AR; Schiappoli M; Passalaqua
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):386-92. PubMed ID: 14768524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.